Recently, oncogenic mutations in EZH2 – an enzyme that catalyzes methylation of the lysine 27 residue of histone H3 (H3K27) - have been found in a subset of GCB DLBCL patients [15], [16], [17]. Here, EZH2 is linked to diffuse large B-cell lymphoma.